Skyscape Web Viewer : Yao & Artusio's Anesthesiology: Problem-Oriented Patient Management : Medication Index

View All
Thyroxine A.5. What are the principles of perioperative donor management? D.2. You have successfully treated the patient's massive hemorrhage. The laboratory values have returned to normal. The patient, however, is still hypotensive despite appropriate intravascular volume replacement and support with vasopressors. What is your concern in this case?
Ticlopidine B.5. What is the conventional recommendation for dual antiplatelet therapy (DAPT) in a patient with previous percutaneous coronary intervention (PCI) undergoing elective noncardiac surgery? B.6. What risk is associated with continuing perioperative antiplatelet therapy? What risk is there with stopping it?
Timolol A.10. Are topically applied ophthalmic medications absorbed systemically? How can this absorption be reduced? Which eye drops can have effects that are of concern to the anesthesiologist? A.7. Is atropine contraindicated in patients with glaucoma?
Timoptic
Tissue plasminogen activator A.10. Why do patients with ESLD have abnormalities of hemostasis? B.4. What types of emergencies can occur during the coiling of an aneurysm, and how should they be managed? C.6. What physiologic disturbances should be anticipated during the second stage (anhepatic phase) of liver transplantation? D.3. Describe the pathophysiology of potential complications following massive transfusion and hematologic resuscitation. What are the risks of thromboembolic complications after intraoperative administration of procoagulants? D.7. What steps can be taken to prevent cerebral vasospasm?
Tizanidine
Tobramycin
Tolazoline
Topiramate
Toradol
Tramadol B.11. What is tramadol? Is it an opioid? B.5. Would you premedicate this patient? Cancer Pain D.2. What is your approach to postoperative pain control? Major and Complex Spine Surgery
Tranexamic acid B.9. What coagulation abnormalities are present after TBI? What modalities can be used to provide hemostasis and reduce intracranial hematoma expansion? C.10. You decide to use rotational thromboelastometry (ROTEM) to guide your resuscitation efforts. After 20 minutes, the results of the ROTEM are normal; however, the field is still bloody. The surgeon suggests tranexamic acid (TXA) for the patient. What is TXA and what is its mechanism of action? Is TXA effective at reducing blood loss in major spine surgery? What are the risks of TXA administration? Is TXA an appropriate choice in this patient? C.17. How is hyperfibrinolysis managed? C.2. Discuss the indications and use of available antifibrinolytic drugs. What dose should be given? Describe the side effects of antifibrinolytic therapy. C.21. What concentrated factors and hemostatic agents are available for bleeding patients? C.7. When should this patient receive tranexamic acid (TXA)? C.8. Why does a coagulopathy ensue and how is it prevented/treated? C.I-17. What antifibrinolytic will you use to reduce blood transfusions? C.II-14. How do you prepare an intravenous (IV) infusion of sodium nitroprusside, nicardipine, and nitroglycerin? What are the usual doses? Which do you prefer to use? Major and Complex Spine Surgery Placenta Previa/Placenta Accreta Spectrum
Tranylcypromine
Triamterene
Triiodothyronine
Trimethoprim C.4. What is modified ultrafiltration (MUF)? D.1. What are the major complications after lung transplantation?
Tromethamine C.16. How are the complications of massive transfusion prevented? C.6. After delivery of the placenta in a cesarean delivery, what maneuvers and drugs can enhance myometrial contractility and therefore decrease blood loss?
Tropicamide
Tubocurarine B.1. How is the choice of NMBA made? C.12. How does burn injury affect the dosing of nondepolarizing neuromuscular blocking agents? C.13. How are neuromuscular blocking agents, such as succinylcholine, atracurium, cisatracurium, vecuronium, pancuronium, rocuronium, and curare, metabolized and eliminated? Which have significant histamine release?
Tylenol
Ultram
Urea
Urokinase
Valproic acid A.2. What is the underlying pathology? A.5. Describe the hematologic side effects of chronic valproic acid therapy. B.1. What preoperative evaluation and testing would you recommend for this patient prior to anesthesia? Coagulopathy D.4. What is the role of antiseizure prophylaxis in the perioperative management of head trauma?
Valsartan B.6. How should the patient's other medications be managed before surgery? Ischemic Heart Disease and Noncardiac Surgery
Vancomycin B.2. How would you premedicate this patient? Why? B.3. How are routine medications and immunosuppressive medications managed in the perioperative period?
Vasopressin
Vecuronium
Venlafaxine B.6. Are there any psychiatric medications he is taking that would impact your anesthetic care? Electroconvulsive Therapy
Verapamil A.14. What is the mechanism of action of the major antihypertensive drugs? A.17. Describe the operative procedure of kidney transplantation. A.6. Which perioperative medical therapies would you employ to reduce the incidence of myocardial ischemia? C.1. Are a central venous pressure (CVP) catheter, an arterial catheter, and a pulmonary artery catheter required for the transplant procedure? C.10. During the surgery, the blood pressure increases to 220/120 mm Hg. How would you treat the hypertension? C.11. What could you do to prevent hypertension during tracheal extubation and emergence? C.11. When would you extubate the trachea in this patient? What could you do to prevent hypertension and tachycardia during extubation and emergence? C.6. Twenty minutes into the procedure with sevoflurane anesthesia, the patient develops increasing tachycardia with ventricular premature beats and mottled skin. What emergency measures should you take? D.1. The patient developed hypertension, BP 210/110 mm Hg, in the postanesthesia care unit. What would you do?